• 1. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl halides Benzyl chlorides

Chemical Profile of 1-(Chloromethyl)-2,3,4-trifluorobenzene (CAS No. 292621-60-4)

1-(Chloromethyl)-2,3,4-trifluorobenzene, identified by its Chemical Abstracts Service number CAS No. 292621-60-4, is a fluorinated aromatic compound that has garnered significant attention in the field of pharmaceutical and materials science due to its unique structural and chemical properties. This compound belongs to the class of halogenated benzenes, which are widely studied for their potential applications in drug synthesis, polymer modification, and as intermediates in organic reactions. The presence of both a chloromethyl substituent and multiple fluorine atoms at specific positions on the benzene ring imparts distinct reactivity and electronic characteristics, making it a versatile building block for further chemical modifications.

The structural framework of 1-(Chloromethyl)-2,3,4-trifluorobenzene consists of a benzene core substituted with three fluorine atoms at the 2, 3, and 4 positions, along with a chloromethyl group attached to the 1-position. This arrangement creates a molecule with a high degree of electron-withdrawing effects due to the fluorine atoms, which can significantly influence the reactivity of the chloromethyl group. The electron density around the benzene ring is altered by the fluorine substitutions, leading to differential reactivity across different positions on the ring. This feature makes the compound particularly useful in selective functionalization reactions, where specific sites on the aromatic ring can be targeted for further derivatization.

In recent years, 1-(Chloromethyl)-2,3,4-trifluorobenzene has been explored as a key intermediate in the synthesis of various pharmacologically active compounds. The chloromethyl moiety is a well-known nucleophilic substitution site, allowing for easy introduction of other functional groups such as amino groups to form amides or ureas. Additionally, the fluorinated aromatic ring can enhance metabolic stability and bioavailability in drug candidates. Several studies have demonstrated its utility in constructing heterocyclic compounds that exhibit antimicrobial and anti-inflammatory properties. For instance, researchers have incorporated this scaffold into quinoline derivatives that show promising activity against resistant bacterial strains.

The fluorine atoms in 1-(Chloromethyl)-2,3,4-trifluorobenzene not only influence electronic properties but also contribute to steric hindrance around the reactive sites. This can be leveraged in designing molecules with improved binding affinities to biological targets. In particular, fluorine-mediated effects have been shown to modulate receptor interactions in drug design. A notable example is its application in developing kinase inhibitors, where fluorinated aromatic rings enhance binding stability by increasing lipophilicity and reducing solvation energy requirements. The compound’s ability to serve as a precursor for such inhibitors has been highlighted in several patents and scientific publications.

From a synthetic chemistry perspective, 1-(Chloromethyl)-2,3,4-trifluorobenzene offers a versatile platform for exploring novel reaction pathways. The combination of electronic and steric effects imposed by its substituents allows for diverse transformations under different reaction conditions. For example, palladium-catalyzed cross-coupling reactions can be employed to introduce additional aryl or vinyl groups onto the benzene ring, expanding its utility in constructing complex molecular architectures. Additionally, nucleophilic aromatic substitutions (SNAr) can be facilitated at positions ortho or para to the chloromethyl group under appropriate conditions.

The pharmaceutical industry has been particularly interested in leveraging the unique properties of 1-(Chloromethyl)-2,3,4-trifluorobenzene for developing next-generation therapeutics. Its incorporation into drug candidates has led to compounds with enhanced pharmacokinetic profiles due to improved lipophilicity and reduced metabolic degradation pathways. Furthermore, its role as an intermediate in synthesizing antiviral agents has been explored recently. Researchers have reported its use in constructing fluorinated nucleoside analogs that exhibit potent activity against viral enzymes critical for replication.

Material scientists have also recognized the potential of this compound in advanced polymer applications. The presence of fluorine atoms imparts thermal stability and chemical resistance to polymers derived from this scaffold. Consequently, 1-(Chloromethyl)-2,3,4-trifluorobenzene has been investigated as a monomer for high-performance resins used in aerospace and electronics industries where durability under extreme conditions is paramount. Its ability to form copolymers with other monomers while maintaining structural integrity has made it a valuable component in developing next-generation materials.

The environmental impact of using 1-(Chloromethyl)-2,3,4-trifluorobenzene as an intermediate has also been considered by researchers aiming for sustainable chemistry practices. Efforts have been made to optimize synthetic routes that minimize waste generation and hazardous byproducts through green chemistry principles such as catalytic processes or solvent-free reactions where feasible. These efforts align with global initiatives promoting eco-friendly chemical manufacturing while maintaining high yields and purity standards required for pharmaceutical applications.

In conclusion, 1-(Chloromethyl)-2,3,4-trifluorobenzene (CAS No. 292621-60-4) represents an intriguing compound with broad applicability across multiple scientific disciplines including pharmaceuticals, materials science, and organic synthesis Its unique structural features—combining both electron-withdrawing fluorine substituents and a reactive chloromethyl group—make it an invaluable building block for innovation-driven research projects aimed at developing novel therapeutics, advanced materials, or sustainable chemical processes The ongoing exploration into its potential applications underscores its significance as a research tool whose versatility continues to inspire new scientific discoveries.

• 243139-71-1(2,4,5-Trifluorobenzyl chloride)
• 114152-20-4(2-(Chloromethyl)-1,3,4-trifluorobenzene)
• 495-07-8(2,5-Difluorobenzyl chloride)
• 21622-18-4(2,3,4,5-Tetrafluorobenzyl Chloride)
• 446-57-1(2,3-Difluorobenzyl Chloride)
• 452-07-3(1-(chloromethyl)-2,4-difluorobenzene)
• 653-35-0(1-(Chloromethyl)-2,3,4,5,6-pentafluorobenzene)
• 60903-84-6(2,3,5,6-Tetrafluoro-4-methylbenzylchloride)
• 107267-44-7(2,3,5,6-Tetrafluorobenzyl Chloride)
• 131803-37-7(1,4-Bis(chloromethyl)-2,3,5,6-tetrafluorobenzene)